Publications by authors named "Alessandra Forcina"

Claim this Profile
T
TROPION-Lung15: a randomized phase III study of osimertinib combined with datopotamab deruxtecan (Dato-DXd) or Dato-DXd alone versus platinum-doublet chemotherapy in patients with -mutated advanced non-small cell lung cancer and whose disease has progressed on prior osimertinib.
Daniel Shao-Weng Tan, Ernest Nadal, Parneet Cheema, Yi-Long Wu, Myung-Ju Ahn, Alessandra Forcina

Ther Adv Med Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I non-small cell lung cancer.
David R Jones, Isabelle Opitz, David Harpole, Jane Yanagawa, Eric Lim, Alessandra Forcina

J Thorac Cardiovasc Surg· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment.
Mark Roschewski, Manish R Patel, Patrick M Reagan, Nakhle S Saba, Graham P Collins, Alessandra Forcina

Clin Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanosphere's Verigene Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance.
Raffaella Greco, Maria Chiara Barbanti, Nicasio Mancini, Laura Infurnari, Renée Pasciuta, Alessandra Forcina

Clin Hematol Int· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation.
Alessandra Forcina, Francesca Lorentino, Vincenzo Marasco, Chiara Oltolini, Magda Marcatti

Biol Blood Marrow Transplant· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients.
Raffaella Greco, Maria Chiara Barbanti, Nicasio Mancini, Lara Crucitti, Chiara Oltolini, Alessandra Forcina

Bone Marrow Transplant· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation.
Alessandra Forcina, Paola M V Rancoita, Magda Marcatti, Raffaella Greco, Maria Teresa Lupo-Stanghellini

Biol Blood Marrow Transplant· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enteric Microbiome Markers as Early Predictors of Clinical Outcome in Allogeneic Hematopoietic Stem Cell Transplant: Results of a Prospective Study in Adult Patients.
Nicasio Mancini, Raffaella Greco, Renée Pasciuta, Maria Chiara Barbanti, Giacomo Pini, Alessandra Forcina

Open Forum Infect Dis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome.
Raffaella Greco, Lara Crucitti, Maddalena Noviello, Sara Racca, Daniele Mannina, Alessandra Forcina

Biol Blood Marrow Transplant· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia.
Matteo G Carrabba, Laurette Tavel, Giacomo Oliveira, Alessandra Forcina, Giacomo Quilici

J Hematol Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs.
Massimo Bernardi, Matteo Carrabba, Carlo Messina, Raffaella Milani, Elisa Sala, Alessandra Forcina

Am J Hematol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias.
Marco Lepore, Claudia de Lalla, S Ramanjaneyulu Gundimeda, Heiko Gsellinger, Michela Consonni, Alessandra Forcina

J Exp Med· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis